The Department of the Navy Bureau of Medicine and Surgery awarded a $195,894.60 firm fixed price delivery order contract to INO Therapeutics LLC, a foreign-owned for-profit company, to provide inhaled nitric oxide (INO) therapy and related medical gases. This contract was issued under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB) and did not have a set-aside designation. INO Therapeutics supplies INO therapy systems and gases to support respiratory treatments and healthcare...
This is a Delivery Order contract awarded by the Defense Health Agency (DHA) to INO Therapeutics LLC, a prime contractor, to provide Nitric Oxide Therapy Services. The contract is a Firm Fixed Price arrangement valued at $295,518.66 and has an ultimate completion date of September 30, 2025. It was awarded on January 1, 2021 under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB) without any set-aside designation. INO Therapeutics is a foreign-owned, for-profit organization that has...
This is a federal contract award for INO Therapy Services valued at $512,930.00, awarded by the Defense Health Agency to INO Therapeutics LLC, a foreign-owned for-profit organization. The contract is a delivery order under the Pharmaceuticals and Drugs GSA Schedule and has a firm fixed price. The contract is to provide inhaled nitric oxide therapy systems and related medical gases to support respiratory treatments and healthcare programs for veterans, service members, and military beneficiaries....
This is a delivery order awarded by the National Institutes of Health (NIH) to INO Therapeutics LLC, a foreign-owned for-profit organization. The $248,887.20 fixed-price contract is for the delivery of inhaled nitric oxide therapy systems and related medical gases to support respiratory treatments and healthcare programs for veterans, service members, and military beneficiaries. The contract was awarded under the General Services Administration (GSA) Pharmaceuticals and Drugs Federal Supply...
This is a federal contract award to INO Therapeutics LLC, a foreign-owned, for-profit company, to provide inhaled nitric oxide gas, delivery systems, and related services to support respiratory treatments and healthcare programs for veterans, service members, and military beneficiaries. The $184,294.00 contract was awarded by the Defense Health Agency and is a Delivery Order under the Pharmaceuticals and Drugs GSA Schedule 61-IB. The contract does not have a set-aside designation. INO...
This is a $200,611.03 firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to INO Therapeutics LLC, a foreign-owned for-profit organization, for the provision of inhaled nitric oxide therapy systems and related medical gases to support respiratory treatments and related healthcare programs for veterans, service members, and military beneficiaries. The contract is under the Pharmaceuticals and Drugs GSA Supply Schedule and does...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to INO Therapeutics LLC, a foreign-owned for-profit company. The $125,334.00 order is for the provision of BASE + 4 NITRIX OXIDE THERAPY and is being fulfilled under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB). The order has a completion date of December 31, 2023 and was awarded on January 1, 2019. INO Therapeutics LLC is an experienced federal contractor, having been...
This is a delivery order awarded by the Department of Veterans Affairs' Bureau of Medicine and Surgery to INO Therapeutics LLC for the purchase of nitric oxide as required. The contract is a Firm Fixed Price award under the Pharmaceuticals and Drugs GSA Schedule with a ceiling value of $160,604.85 and a period of performance through December 31, 2017. This contract was not set aside for any small business category. INO Therapeutics is a foreign-owned, for-profit company that specializes in...
This is a delivery order awarded by the Defense Health Agency (DHA) to INO Therapeutics LLC, a foreign-owned, for-profit organization specializing in providing inhaled nitric oxide therapy systems and related medical gases to federal government healthcare agencies. The $347,721.90 fixed-price contract is for a chemistry analyzer and reagents, and has an ultimate completion date of May 14, 2029. The contract was awarded under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB), and does...
This is a firm-fixed-price delivery order awarded by the Veterans Integrated Service Network 1 of the U.S. Department of Veterans Affairs to INO Therapeutics LLC, a foreign-owned, for-profit company. The $94,046.29 contract is for the delivery of 250 hours of nitric oxide gas, which is used to improve oxygenation in term and near-term neonates. The contract is under the Pharmaceuticals and Drugs GSA Schedule and does not have a set-aside designation. INO Therapeutics has been a prime...